V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20224190 | 20084867 | 1.78 | 130 | null | 2017-03-05 | 2017-03-26 | Enzalutamide | 1 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100106273 |
| 20224191 | 20084868 | 1.69 | 88.6 | Palliative (P) | 2016-03-28 | 2016-04-07 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101375597 |
| 20224192 | 20084869 | 1.66 | 84.4 | Palliative (P) | 2019-08-04 | 2019-09-09 | OCTREOTIDE | 02 | N | SCALOP-2 TRIAL | 101675954 |
| 20224204 | 20084870 | 1.65 | 71.6 | Palliative (P) | null | 2016-09-20 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100143984 |
| 20224215 | 20084871 | 0 | 85.8 | Palliative (P) | 2016-05-20 | 2016-06-04 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100739288 |
| 20224226 | 20084872 | 1.74 | 69.7 | 03 | 2019-03-31 | 2019-03-31 | Enzalutamide | 02 | N | TRASTUZUMAB | 100889475 |
| 20224233 | 20084873 | 0 | 0 | Palliative (P) | 2017-02-16 | 2017-02-16 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 100006410 |
| 20224237 | 20084874 | 1.68 | null | Palliative (P) | 2020-02-14 | 2020-02-18 | Enzalutamide | N | N | CAPECITABINE + TEMOZOLOMIDE | 100208209 |
| 20224240 | 20084875 | 1.72 | 87 | Curative (C) | 2022-01-08 | 2022-01-09 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101837858 |
| 20224244 | 20084876 | 1.68 | 69 | Palliative (P) | 2018-12-30 | 2018-12-30 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100781263 |
| 20224249 | 20084877 | 1.5 | 65.8 | Palliative (P) | 2018-11-24 | 2018-12-17 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101724163 |
| 20224253 | 20084878 | 1.73 | 66 | Neo-adjuvant (N) | 2021-03-07 | 2021-03-15 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 101708078 |
| 20224259 | 20084879 | 1.85 | 78.8 | 03 | 2018-07-29 | 2018-08-02 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101844572 |
| 20224260 | 20084880 | 1.82 | 88.5 | Neo-adjuvant (N) | 2018-05-07 | 2018-05-19 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101152026 |
| 20224270 | 20084881 | 1.59 | 75 | null | 2016-09-05 | 2016-09-06 | TRASTUZUMAB | 02 | null | SCALOP-2 TRIAL | 100704916 |
| 20224272 | 20084882 | 1.75 | 93.4 | Palliative (P) | 2019-04-04 | 2019-04-18 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 101253188 |
| 20224274 | 20084883 | 0.69 | null | Palliative (P) | null | 2019-12-12 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100130441 |
| 20224279 | 20084884 | 1.7 | 95.25 | Palliative (P) | 2016-03-07 | 2016-03-08 | Enzalutamide | 99 | N | ECF | 101063211 |
| 20224287 | 20084885 | 1.8 | 74.4 | Palliative (P) | 2016-10-07 | 2016-10-14 | Enzalutamide | 02 | N | CARBOPLATIN + GEMCITABINE | 100238247 |
| 20224288 | 20084886 | 1.6 | 51.5 | null | 2020-02-20 | 2020-02-27 | Carboplatin AUC 2 - 5 | 02 | Y | CARBOPLATIN | 100122730 |
| 20224290 | 20084887 | 1.9 | 67 | Neo-adjuvant (N) | 2018-03-12 | 2018-03-12 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101251480 |
| 20224291 | 20084888 | 1.75 | 114 | Palliative (P) | 2015-01-14 | 2015-01-31 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101095080 |
| 20224294 | 20084889 | 1.75 | 74.4 | Curative (C) | 2016-06-23 | 2016-06-23 | Enzalutamide | 02 | N | CISPLATIN | 101022213 |
| 20224302 | 20084890 | 1.6 | 74 | Palliative (P) | 2019-06-20 | 2019-06-27 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100146614 |
| 20224306 | 20084891 | 1.77 | 84 | Curative (C) | 2019-11-29 | 2019-12-12 | Enzalutamide | 02 | N | CISPLATIN | 101642818 |
| 20224308 | 20084892 | 1.7 | 62.1 | Palliative (P) | null | 2018-07-23 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100625159 |
| 20224321 | 20084893 | 1.59 | 106.2 | Neo-adjuvant (N) | 2016-06-07 | 2016-06-07 | Enzalutamide | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100254954 |
| 20224323 | 20084894 | 1.66 | 43.2 | Palliative (P) | 2020-10-19 | 2020-10-24 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101197769 |
| 20224329 | 20084895 | 1.66 | 40.4 | Palliative (P) | 2019-01-18 | 2019-01-20 | Enzalutamide | 02 | N | CETUXIMAB | 100344663 |
| 20224332 | 20084896 | 1.6 | 66.5 | Palliative (P) | 2016-03-01 | 2016-03-20 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100611112 |
| 20224334 | 20084897 | 1.83 | 54 | Neo-adjuvant (N) | 2017-02-24 | 2017-03-22 | CARBOPLATIN + PACLITAXEL + RT | 2 | Y | CARBOPLATIN + PACLITAXEL + RT | 100165882 |
| 20224338 | 20084898 | 1.68 | 71 | null | 2017-03-10 | 2017-03-25 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100067863 |
| 20224340 | 20084899 | null | 70.2 | Adjuvant (A) | 2019-12-20 | 2019-12-21 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100941352 |
| 20224352 | 20084900 | 1.61 | 91 | Palliative (P) | 2020-02-28 | 2020-02-28 | Enzalutamide | 02 | N | TRASTUZUMAB | 100951481 |
| 20224355 | 20084901 | 1.75 | 75.3 | Palliative (P) | 2017-09-23 | 2017-10-05 | Enzalutamide | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100930234 |
| 20224359 | 20084902 | 1.65 | 86 | Palliative (P) | 2018-07-07 | 2018-08-16 | Trastuzumab 21 day loading dose | 02 | N | TRASTUZUMAB | 100589007 |
| 20224360 | 20084903 | 1.54 | 80.4 | Curative (C) | 2017-07-04 | 2017-07-14 | Enzalutamide | null | null | SCALOP-2 TRIAL | 101589696 |
| 20224362 | 20084904 | 1.6 | 83 | null | 2017-01-13 | 2017-01-18 | Enzalutamide | N | null | ENZALUTAMIDE | 100169664 |
| 20224365 | 20084905 | 1.7 | 68.1 | null | 2019-03-18 | 2019-03-23 | Enzalutamide | 02 | null | CARBOPLATIN | 100193583 |
| 20224366 | 20084906 | 1.48 | 83.2 | Palliative (P) | 2020-01-31 | 2020-01-31 | Cetuximab 14 day | N | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100266032 |
| 20224367 | 20084907 | 1.82 | null | Neo-adjuvant (N) | 2016-02-09 | 2016-02-09 | Enzalutamide | 02 | N | CISPLATIN | 101421836 |
| 20224368 | 20084908 | 1.65 | 77 | Palliative (P) | 2019-10-22 | 2019-10-22 | Oxaliplatin + Raltitrexed | null | N | OXALIPLATIN + RALTITREXED | 100004994 |
| 20224374 | 20084909 | 1.8 | 52.2 | Palliative (P) | 2018-08-24 | 2018-09-01 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100532288 |
| 20224381 | 20084910 | 1.64 | 78 | Curative (C) | null | 2016-11-05 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | TRASTUZUMAB | 100311757 |
| 20224382 | 20084911 | 1.57 | 59.7 | Neo-adjuvant (N) | 2017-01-06 | 2017-01-06 | Capecitabine + Cisplatin + RT | 02 | Y | CAPECITABINE + CISPLATIN + RT | 101445290 |
| 20224386 | 20084912 | 1.63 | 635 | Adjuvant (A) | 2019-05-19 | 2019-05-29 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 100600064 |
| 20224405 | 20084913 | 1.7 | 94 | null | 2018-04-03 | 2018-07-28 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 100885906 |
| 20224406 | 20084914 | 1.75 | 94 | Curative (C) | null | 2016-02-06 | Enzalutamide | N | N | OCTREOTIDE | 101106755 |
| 20224408 | 20084915 | 1.54 | null | Palliative (P) | 2019-06-19 | 2019-06-20 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 101169978 |
| 20224414 | 20084916 | 0 | 0 | Neo-adjuvant (N) | 2017-03-19 | 2017-03-23 | Capecitabine + Cisplatin + RT | N | N | CAPECITABINE + CISPLATIN + RT | 101401284 |